The Cigna Group (NYSE:CI) Shares Sold by Thompson Investment Management Inc.

Thompson Investment Management Inc. lessened its position in shares of The Cigna Group (NYSE:CI) by 0.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 21,946 shares of the health services provider’s stock after selling 66 shares during the quarter. The Cigna Group makes up about 1.2% of Thompson Investment Management Inc.’s holdings, making the stock its 26th largest position. Thompson Investment Management Inc.’s holdings in The Cigna Group were worth $7,971,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Seizert Capital Partners LLC increased its position in The Cigna Group by 195.8% during the 4th quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock worth $9,627,000 after purchasing an additional 21,280 shares in the last quarter. Roman Butler Fullerton & Co. grew its holdings in The Cigna Group by 61.4% in the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after buying an additional 3,539 shares during the period. TFO Wealth Partners LLC grew its holdings in The Cigna Group by 98,980.0% in the 4th quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock valued at $1,497,000 after buying an additional 4,949 shares during the period. Ellsworth Advisors LLC purchased a new stake in The Cigna Group in the 4th quarter valued at about $4,377,000. Finally, Sapient Capital LLC purchased a new stake in The Cigna Group in the 4th quarter valued at about $2,811,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Down 0.3 %

Shares of NYSE CI traded down $0.93 during mid-day trading on Wednesday, reaching $337.87. 339,828 shares of the company traded hands, compared to its average volume of 1,607,723. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a market cap of $95.98 billion, a PE ratio of 27.68, a price-to-earnings-growth ratio of 1.03 and a beta of 0.53. The company’s fifty day moving average is $342.12 and its two-hundred day moving average is $332.66. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30. The business had revenue of $57.25 billion for the quarter, compared to analyst estimates of $56.59 billion. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The firm’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.41 EPS. On average, analysts expect that The Cigna Group will post 28.47 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th were issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date of this dividend was Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is currently 45.98%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CI. Morgan Stanley reiterated an “overweight” rating and set a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 12th. Oppenheimer boosted their target price on The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Piper Sandler assumed coverage on The Cigna Group in a report on Wednesday. They set an “overweight” rating and a $400.00 target price for the company. Finally, JPMorgan Chase & Co. boosted their price target on The Cigna Group from $432.00 to $435.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $376.20.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 547 shares of the firm’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the sale, the director now owns 5,471 shares of the company’s stock, valued at approximately $1,812,979.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other The Cigna Group news, Director Elder Granger sold 547 shares of the firm’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the sale, the director now owns 5,471 shares in the company, valued at approximately $1,812,979.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the sale, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The disclosure for this sale can be found here. Insiders have sold 18,193 shares of company stock valued at $6,321,404 in the last 90 days. 0.60% of the stock is currently owned by insiders.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.